Differential Diagnosis of Hypercortisolism

This episode, titled ‘Differential Diagnosis of Hypercortisolism,’ features panelists discussing the challenges of distinguishing hypercortisolism from common cardiometabolic and endocrine conditions that share similar clinical features. The expert faculty examine the substantial overlap between hypercortisolism and disorders frequently encountered in clinical practice, emphasizing how these similarities can complicate diagnosis and delay appropriate evaluation.

Throughout the conversation, the panel of experts highlights the overlap between hypercortisolism and conditions such as central obesity, insulin resistance, hypertension, and polycystic ovary syndrome. They discuss how many patients with hypercortisolism initially present with symptoms commonly attributed to these more prevalent disorders, making it difficult to determine whether cortisol excess is contributing to the clinical picture. The faculty also explore the relationship between hypercortisolism and sleep disorders, including obstructive sleep apnea, as well as psychiatric conditions such as depression and anxiety that may be associated with elevated cortisol levels.

The panelists further address the diagnostic challenges posed by non-neoplastic forms of endogenous hypercortisolism, including alcohol-related hypercortisolism and other conditions that can produce biochemical and phenotypic findings similar to those observed in Cushing syndrome. They explain how these overlapping presentations can create uncertainty when interpreting clinical findings and laboratory results, particularly in patients with milder manifestations of disease.

As the discussion progresses, the faculty share insights into their diagnostic approach when evaluating patients with suspected hypercortisolism and emphasize the importance of considering the full clinical context. The episode highlights the complexity of differential diagnosis and underscores the need for careful assessment when determining whether cortisol excess is the primary driver of a patient’s metabolic and endocrine abnormalities.

In the next episode, ‘Delayed Diagnosis in Hypercortisolism’, panelists will discuss why symptom variability, overlapping metabolic conditions, and complex testing can contribute to delayed diagnosis. The panel of experts will also examine the challenges clinicians face when distinguishing hypercortisolism from more common disorders that share similar clinical features.